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Abstract
Three novel water-soluble ruthenium complexes having differently bound alliin ligand were 
prepared by solution synthesis and characterized by chemical analysis, infrared, mass, nuclear 
magnetic resonance and electron paramagnetic resonance spectroscopies. The reaction of 
(de)protonated alliin with cis,fac-[RuCl2(dmso-S)3(dmso-O)] in the presence of silver triflate 
afforded cationic [RuII(dmso-S)2(alliin-NS)2]2+ (1) and neutral [RuII(dmso-S)(OH2)(alliin-
NO)2] (2), while [RuIII(NH3)5(alliin-O)]2+ (3) was prepared starting from [RuCl(NH3)5]Cl2. 
The interaction of the complexes with bovine serum albumin and apo-transferrin was 
investigated by spectrofluorimetry. Complexes showed higher affinity toward BSA compared 
to apo-transferrin. Deeper insight into the nature of the binding forces between the complexes 
and BSA was provided from the thermodynamic measurements, synchronous and 3D 
emission spectra. Different coordination modes of alliin in complexes (1) – (3) affect the type 
of the binding forces between the complexes and BSA. Complexes having O-bound alliin, (2) 
and (3), predominantly interact with the BSA through hydrogen bonding and van der Walls 
interactions, while the hydrophobic forces govern the interaction of (1) with BSA. In vitro 
antiproliferative and antimicrobial activity of the complexes and alliin was also tested. 
Key words: ruthenium, alliin, S-Allyl-L-cysteine sulfoxide, coordination modes, BSA.
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1. Introduction
Solutions to the challenges posed to inorganic chemists by modern scientific era are often 
sought in the chemistry of coordination compounds. The predictability of the properties 
grounded on the chemical portrait of compounds, coupled with the very wide variety of metal 
centers, donor atoms and versatile stereochemistry of ligands represent an enormous potential 
in designing the exceedingly specific and highly active coordination compounds toward pre-
defined target or chemo-physical process. In light of this, coordination chemistry offered 
brilliant solutions in fields ranging from catalysis to medical applications. 
Platinum group metals, especially platinum and very attractive alternative ruthenium, are the 
most extensively studied due to their potential therapeutic applications in treatment of the 
malignant diseases.1-4 Due to the empirically established fact that the coordination of organic 
molecules to metal ions regularly results in improved activity of the metal complexes, very 
commonly immanently biologically active ligands are the choice for the coordination to the 
metal ions in designing the new metal-based therapeutics.5-11 A very tempting option is alliin. 
Alliin, namely S-Allyl-L-cysteine sulfoxide, is an unsaturated cysteine-derived amino acid 
naturally occurring in garlic bulbs.12 Many health-beneficial properties of garlic are attributed 
to alliin and allicin, a highly active thiosulfinate compound that is produced by alliinase-
mediated alliin decomposition.13 Allicin is relatively unusable compound and any therapeutic 
use of allicin should include its generation in situ from more stable alliin. Production rate of 
allicin and the kinetic control of its release at targeted place could be controlled by 
complexation. Additionally, alliin’s water-solubility, biological recognizability along with 
predispositions for strong biological activity coupled with diversity of coordination properties 
inspired the synthesis of palladium(II)14 and platinum(II)15 complexes. Also, complexes of 
deoxyalliin and other alliin-like ligands were prepared.16-21 
As stereochemically flexible ligand, having several potentially donor- atoms, including 
nitrogen, sulfur and oxygen, alliin can coordinate metal ions in different fashions as mono, bi 
and tridentate neutral or monobasic ligand. The different coordination modes of the ligand 
affect chemical and physical properties of corresponding complex.22-25 This opens the 
possibility for controlling the properties of complexes with alliin including those relevant for 
biological application such as inertness-lability, water-solubility, lipophilicity, charge etc.
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Important targets of alliin – metal complexes might be proteins, the most abundant 
bimolecular targets in blood. Their importance is a reflection of the fact that alliin is absorbed 
directly to blood26 and that the action mode of allicin is related to S-containing proteins.27 
Also, many biologically active ruthenium complexes bind proteins.28-30
Inspired by the above mentioned facts, we prepared and characterized three new heteroleptic 
water-soluble ruthenium - alliin complexes emphasizing the different coordination abilities of 
alliin. Also, we investigated their interaction with apo-transferrin and bovine serum albumin 
and tested their in vitro antiproliferative and antimicrobial activity.  
2. Experimental
2.1. Chemicals
All chemicals were supplied from commercial sources and used as received without further 
purification unless otherwise indicated. L-Cysteine (p.a.) was obtained from Sigma and allyl 
bromide from Merck and it was distilled twice prior the use. Cis,fac-[RuCl2(dmso-S)4(dmso-
O)] and [Ru(NH3)5Cl]Cl2 were prepared by published procedures.31, 32 Lyophilized powder of 
bovine serum albumin (≥ 96%) and human apo-transferrin (≥ 97%) were purchased from 
Sigma.
2.2. Physical measurements 
Elemental analysis was carried out using Perkin Elmer 2400 Series CHNS/O analyzer. 
Ruthenium content was determined by published procedure.33 Mass spectra were recorded 
using 4800 Plus MALDI TOF/TOF analyzer in the positive ion reflector mode in 10 – 2000 
Da region using α-cyano-4-hydroxycinnamic acid matrix. 1H and 13C NMR spectra were 
collected using NMR Bruker Avance 600 instrument from D2O or MeOH-d4 solution at 600 
and 150 MHz, respectively using Me4Si as internal standard. Infrared spectra were recorded in 
4000 – 400 cm-1 region as KBr pallets using Perkin Elmer BX FTIR. Fluorescence 
measurements were done using Perkin Elmer LS 55 Luminescence. The X-band ESR 
measurements have been performed on a Bruker Elexsys 580 FT/CW spectrometer in the 
range from liquid nitrogen to room temperature. The microwave frequency was around 9.7 
GHz, the magnetic field modulation amplitude 0.5 mT and the modulation frequency 100 
kHz.
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2.3. Interaction with proteins
Interaction with proteins was carried out in 10 mM Tris-HCl buffer solution at pH 7.42. In the 
case of apo-transferrin, solution additionally contained 25 mM NaHCO3. Stock solutions of 
proteins (~ 1 µM) were prepared prior measurements and were not used longer than 2 days. 
Protein concentrations were determined spectrophotometrically using extinction coefficient of 
43 824 M-1 cm-1 for BSA and 83 800 M-1 cm-1 for apo-transferrin. Stock solutions of 
complexes and alliin (~ 0.4 mM) were prepared in water.
Titration experiments were carried out at controlled temperature (± 0.1°C) by adding the 
microliters amounts (10 – 60 µL) of stock solution of complex to protein solution (2.000 mL) 
with equilibration time of 2 minutes. 
Emission spectra were recorded in 290 – 420 nm range for BSA and 300 – 400 nm range for 
apo-transferrin with excitation wavelength at 278 nm in both cases. Synchronous fluorescence 
spectra of BSA in the absence and presence of an increasing concentrations of complexes 
were recorded in 250 – 310 nm range at Δλ = 15 nm and Δλ = 60 nm. Three-dimensional 
fluorescence spectra were recorded in 200 – 500 nm emission range with 200 – 350 nm 
excitation range. 
2.4. In vitro biological activity
Antiproliferative activities of complexes and ligand were tested at several cell lines including 
HeLa (cervical carcinoma), SW620 (colorectal adenocarcinoma, metastatic), MCF-7 (breast 
adenocarcinoma), CFPAC-1 (ductal pancreatic adenocarcinoma) and HFF-1 (foreskin 
fibroblasts). The cell growth rate was evaluated by performing the MTT assay.34 The IC50 
values for each compound were calculated from dose-response curves using linear regression 
analysis. More details is given in Supplement. 
Antimicrobial activity was tested on Gram-positive bacteria Staphylococcus aureus, Gram-
negative bacteria Pseudomonas aeruginosa, Escherichia coli and fungi Candida albicans. 
The diameter of the inhibition zone of bacterial growth was measured after applying an 
aliquot (50 μL) of aqueous solution of the tested agent (2 mg mL−1) into the drilled wells and 
incubating it for 24 h at 37°C. Vancomycin, gentamicin, and nystatin were used as positive 
controls and water as negative control.
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2.5. Synthesis
2.5.1. Synthesis of ligand
L-Deoxyalliin and (±)-L-Alliin were prepared by reported procedures with slight 
modifications.35-37 
Synthesis of L-Deoxyalliin (S-Allyl-L-cysteine)
Ethanol-water mixture (240 mL; 5/1, v/v) was placed in a 500 mL Erlenmeyer flask equipped 
with gas purging inlet and magnetic stir bar. Potassium hydroxide (18.52 g; 0.33 mol) was 
dissolved in ethanol-water mixture after which a clear solution was deaerated by purging the 
argon gas. To thus obtained solution L-cysteine (20 g; 0.165 mol) was added portion wise and 
the mixture was stirred until complete dissolution, after witch allyl bromide (19.96 g; 0.165 
mol) was added drop wise. A clear solution was stirred at ambient temperature for next 24 
hours after which was acidified by glacial acetic acid to pH 5.5. A white powder of L-
deoxyalliin was filtered through fritted glass funnel B4, washed with ice-cold ethanol (40 mL) 
and dried under reduced pressure. Yield: 20.33 g (76%). 
Synthesis of (±)-L-Alliin (S-Allyl-L-cysteine sulfoxide) - HL
The suspension of deoxyalliin (6.00 g; 0.037 mol) in water (40 mL) was magnetically stirred 
at room temperature for one hour after which hydrogen peroxide (30% w/v, 4.22 g; 0.037 
mol) was added drop wise within one hour. The ivory white suspension was stirred for 24 
hours at room temperature, after which the volume was reduced by vacuum distillation up to 
20 mL. The solution was acidified with few drops of acetic acid and poured to a vigorously 
stirred acetone (200 mL). The white bulky product was filtered through fritted glass funnel 
B2, thoroughly washed with acetone and vacuum dried. Purification was carried out from 
saturated aqueous solution by addition of acetone. Yield: 4.42 g (64%).
2.5.2. Synthesis of complexes
Synthesis of complex [RuII(DMSO-S)2(HL-NS)2](OTf)2 (1)
To methanol solution (10 mL) of cis-dichloridotetrakis(dimethylsulfoxide)ruthenium(II) (100 
mg; 0.206 mmol) silver triflate (106 mg; 0.413 mmol) dissolved in methanol (10 mL) was 
added and the resulting mixture was magnetically stirred for an hour at reflux temperature. 
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After cooling to room temperature silver chloride was filtered off. Alliin (77 mg; 0.413 mmol) 
was added to the yellow filtrate and resulting mixture was refluxed for five hours changing its 
color to light brown. After cooling to room temperature reaction mixture was filtered through 
blue ribbon and yellow filtrate was evaporated till dryness. Thus obtained orange-yellow 
gluey mass was dissolved in acetone (10 mL), filtered and product (1) was precipitated by 
slow addition of diisopropyl ether (25 mL). The bulky yellow precipitate was filtered off, 
washed with diethyl ether (10 mL) and recrystallized from acetone – diisopropyl ether 
mixture (1/1, v/v). 
Bis(2-amino-κN-3-[(S)-prop-2-enylsulfinyl-κS]propanoic acid)bis(dimethylsulfoxide-κS)
ruthenium(II) trifluoromethanesulfonate (1). Yield: 50 mg (27 %). Anal. Calc. (%) for 
C18H34F6N2O14RuS6 (Mr = 909.92): C, 23.76; H, 3.77; N, 3.08; Ru, 11.11; Found (%): C, 
23.56; H, 3.67; N, 3.59; Ru, 11.01. IR (KBr) ν (cm-1), intensity: 1738 m νs(COOH), 1640 s 
νs(C=C), 1565 m δ(NH2), 1404, 1386 w δ(CH3), 1277 s νa(S=O), 1089, 1032 m νa(S-O), 948 
w νs(C-N). HR MALDI-TOF/TOF MS for C16H34N2O8RuS4 Found (Calc.): 612.0247 
(612.0260) [M]+. 1H NMR (600 MHz, Methanol-d4) δ / ppm: 5.98 – 5.91 (m, H5), 5.71 – 5.66 
(m, H5, 2 H6a), 5.53 – 5.48 (m, 2 H6b), 3.84 – 3.78 (m, H4a), 3.73 – 3.68 (m, H4a, H4b), 
3.63 – 3.58 (m, H4b), 3.43 – 3.34 (m, 9 H(DMSO-S)), 3.24 – 3.19 (m, 4 H3), 3.02 – 2.94 (m, 
H2), 2.91 – 2.84 (m, H2), 2.66 (s, 3 H(DMSO)). 13C NMR (151 MHz, MeOD) δ / ppm: 
168.36 (s, C1), 125.11 (s, C5), 123.95 (s, C6), 120.33 (q, J = 318.4 Hz, CF3SO3), 57.61 (s, 
C3), 55.76 (s, C4), 55,23 (s, C2), 47.62 (hept, J = 42.8, 21.4 Hz, C-DMSO).
Synthesis of [RuII(DMSO-S)(H2O)(L-NO)2] × 3H2O (2)
Acetone solution (10 mL) of silver triflate (106 mg; 0.413 mmol) was added to a stirred 
solution of cis-dichloridotetrakis(dimethylsulfoxide)ruthenium(II)  (100 mg; 0.206 mmol) in 
acetone (15 mL) and the resulting mixture was refluxed for two hours, cooled to room 
temperature and silver chloride was filtered off. The yellow filtrate was mixed with earlier 
prepared well-stirred methanol (25 mL) solution of alliin (77 mg; 0.413 mmol) deprotonated 
by aqueous potassium hydroxide (23 mg; 0.413 mmol in 0.10 mL) and the mixture was 
refluxed for two hours changing its color to light brown. After standing overnight at ambient 
temperature reaction mixture was filtered through blue ribbon. The volume of the yellow 
brown filtrate was reduced to 5 mL under vacuum and diisopropyl ether (15 mL) was added 
drop wise. The light brown substance was filtered off, washed with acetone (5 mL) and 
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vacuum dried. Recrystallization was carried out from dimethylsulfoxide-water mixture (2 mL, 
1/1, v/v) by slow addition of the acetone (5 mL). 
bis(2-amino-κN-3-[(S)-prop-2-enylsulfinyl]propanoato-κO) (aqua )(dimethylsulfoxide-κS) 
ruthenium(II) trihydrate (3). Yield: 60 mg (48%). Anal. Calc. (%) for C14H34N2O11RuS3 (Mr = 
603.69): C, 27.85; H, 5.68; N, 4.64; Ru, 16.74; Found (%): C, 27.62; H, 4.49; N, 4.38; Ru, 
16.41. IR (KBr) ν (cm-1), intensity: 1632 s νas(COO-)+νs(C=C), 1585 m δ(NH2), 1405, 1383 w 
δ(CH3), 1072, 1021 m νa(S-O), 943 m νs(C-N). HR MALDI-TOF/TOF MS for 
C14H30N2O8RuS3 Found (Calc.): 553.1760 (553.0300) [M+H]+. 1H NMR (600 MHz, 
Methanol-d4) δ / ppm: 6.05 – 5.91 (m, H5), 5.72 – 5.65 (m, H5), 5.62 – 5.41 (m, 4 H6a,b), 
4.27 – 4.11 (m, 2 H4a), 4.10 – 3.94 (m, 2 H4b), 3.78 (s, 4 H(NH2)), 3.52 – 3.33 (m, 6 
H(DMSO-S)), 3.32 – 3.17 (m, 4 H3a,b), 2.68 (s, 1 H(DMSO)), 2.60 – 2.10 (m, 2 H2).
Synthesis of [RuIII(NH3)5(L-O)](OTf)2 (3)
Aqueous solution (10 mL) of silver triflate (351 mg; 1.367 mmol) was added to a suspension 
of pentamminechloridoruthenium(III) chloride (200 mg; 0.684 mmol) in water (10 mL) and 
the resulting mixture was magnetically stirred for half an hour after which silver chloride was 
filtered off. An aqueous solution (30 mL) of alliin (127 mg; 0.684 mmol) deprotonated by 
potassium hydroxide (38 mg; 0.684 mmol) was added to the filtrate. The mixture was 
magnetically stirred and heated in open air flask at 65°C for ten hours with concomitant 
reduction of the volume to 5 mL changing its color over cyclamen red to brown. Methanol (20 
mL) was added to the brown solution and mixture was kept in ice for an hour to complete 
precipitation, after which black substance was filtered off, washed with methanol (5 mL) and 
dried under vacuum. 
Pentaammine(2-amino-3-[(S)-prop-2-enylsulfinyl]propanoato-κO)ruthenium(III) 
trifluoromethanesulfonate (3). Yield: 119 mg (26%). Anal. Calc. (%) for C8H25F6N6O9RuS3 
(Mr = 660.58): C, 14.55; H, 3.81; N, 12.72; Ru, 15.30; Found (%): C, 14.72; H, 4.27; N, 
12.05; Ru, 15.25. IR (KBr) ν (cm-1), intensity: 1629 vb s νas(COO-)+νs(C=C)+δd(NH3), 1387  
νs(COO-), 1287 m δd(NH3), 1279 s νa(S=O), , 1032 m νa(S-O), 998 m νs(C-N). HR MALDI-
TOF/TOF MS for C6H25N6O3RuS Found (Calc.): 364.0596 (364.0840) [M+H]+. 1H NMR 
(600 MHz, D2O) δ / ppm: 6.00 – 5.96 (m, H5), 5.55 – 5.52 (m, H6a), 5.46 (dt, J = 16.7, 8.4 
Hz, H6b), 4.16 – 4.10 (m, H4a), 4.04 – 3.98 (m, H4b), 3.80 (dd, J = 13.6, 7.7 Hz, H2), 3.57 – 
3.39 (m, 2 H3a,b), 3.22 (s, 2 H(NH2)), 2.44 – 2.13 (m, vb, 15 H(NH3)). 13C NMR (151 MHz, 
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Deuterium Oxide) δ / ppm: 175.07 (s, C1), 125.43 (s, C5), 124.84 (s, C6), 119.56 (q, J = 
317.4 Hz, CF3SO3), 63.11, 62.86 (s, C2), 61.25, 60.85 (s, C3), 56.51, 56.08 (s, C4).
3. Results and Discussion
3.1. Synthesis
Ligand (±)-L-Alliin was prepared by oxidation of deoxyalliin in aqueous solution by 
hydrogen peroxide and precipitated by acetone (Fig. 1). Deoxyalliin was prepared by the 
condensation reaction of deprotonated L-cysteine and allyl bromide in ethanol-water mixture 
under inert atmosphere at room temperature. Precipitation of the product was induced by 
acidifying the reaction mixture with acetic acid until pH 5.50 was reached.
NH2
HO
O
SH + Br
NH2
HO
O
SEtOH:H2O 5/1 v/v
1) 2eq NaOH; stirring 24 h, Ar
2) HOAc, pH = 5.50
NH2
HO
O
S
NH2
HO
O
S
O
+
1) 1 eq 30% H2O2;
stirring 24 h, rt
2) precip. Me2CO
(±)-L-AlliinL-Deoxyalliin
NH2
HO
O
S
O
Figure 1. Preparation of deoxyalliin and alliin.
Ruthenium complexes with alliin (1) – (3) were prepared by several step solution synthesis. 
Complexes (1) and (2) were prepared starting from cis-[RuCl2(dmso)4], while complex (3) 
was prepared from [RuCl(NH3)5]Cl2. Complexes (1) and (2) have diamagnetic octahedrally 
coordinated Ru(II) metal center with two bidentate alliin molecules and two monodentate 
solvent molecules, while complex (3) has paramagnetic octahedrally coordinated Ru(III) with 
five ammonia molecules and one monodentate anionic O-bonded alliin ligand (Fig. 2).
Complexes (1) and (2) were prepared by silver triflate assisted substitution of chlorido ligands 
from cis-[RuCl2(dmso)4], after which alliin was added to the reaction mixture in molar ratio 
1:2. In the case of complex (2) alliin was deprotonated by aqueous potassium hydroxide prior 
the addition to tempt complexation of Ru(II) through carboxylate oxygen. Cationic complex 
(1), having two alliin molecules bound as bidentate neutral N,S-donor ligands and two S-
bonded dimethyl sulfoxide molecules as coligands, was isolated as triflate salt from methanol 
by addition of diisopropyl ether. In neutral complex (2) two alliin ligands are bound to Ru(II) 
as bidentate anionic O,N-donor ligands, while water and one S-bonded dimethyl sulfoxide 
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molecule occupy fifth and sixth coordination position. Complex (2) was recrystallized from 
DMSO-water mixture and consequently isolated as hydrate. 
Complex (3) was prepared substituting the chlorido ligand from [RuCl(NH3)5]2+ by 
deprotonated alliin in aqueous solution. Two anionic chlorides from [RuCl(NH3)5]Cl2 were 
precipitated as silver salt prior the addition of alliin. Cationic complex (3) was precipitated as 
triflate salt after addition of methanol and cooling the reaction mixture. 
Synthetic procedures for complexes (1) – (3) were carefully design to show that protonation 
state of alliin and the presence of different coligands bound to ruthenium center can result in 
different coordination modes of alliin. This is particularly important from the aspect of the 
possible control of the properties of the complex compounds since it is well documented that 
different coordination modes of the ligand can affect chemical or physical properties of the 
complex.22-25 
All three isolated complexes are highly soluble in water. Complexes (1) and (2) are also 
soluble in most of the organic polar solvents. Complexes (1) and (2) are yellow to light brown 
substances, while complex (3) is black powder. All three complexes have distinctive garlic-
like flavor when grinded.  
S
NH2
O
O
O Ru
H3N
NH3H3N
NH3
NH3
2+
S
NH2
OHO
O
Ru
SO(CH3)2
SO(CH3)2
S
H2N
HO
O O
2+
S
H2N
O
O
O
Ru
OH2
SO(CH3)2
(1) (2) (3)
S
O
NH2
OO
Figure 2. Different binding modes of alliin in ruthenium complexes (1) – (3).
3.2. Characterization
The formulation and characterization of ruthenium – alliin complexes (1) – (3) was made by 
elemental analysis, mass spectrometry, infrared, 1H and 13C NMR and EPR spectroscopy.
The results of the chemical analysis of C, H, N and Ru content confirms proposed formulation 
and good purity of new ruthenium – alliin complexes. The mass spectra of complexes (1) – 
(3) showed typical isotopic ruthenium distribution for anticipated molecular ions. Molecular 
ions, [M]+ for (1) and [M+H]+ for (2) and (3), were observed at 612.03, 553.18 and 364.06 
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Da, respectively which is consistent with [Ru(alliin)2(dmso)2] entity for (1), 
[Ru(alliin)2(dmso)(H2O)] for (2) and [Ru(NH3)5(alliin)] entity for (3) (Fig. S1 – S6).
Different coordination modes of alliin in ruthenium complexes (1) – (3) were indicated by 
infrared spectra. Alliin is a stereochemically flexible ligand having several potentially donor 
atoms and thus it can coordinate metal ions in several fashions. Due to the presence of 
nitrogen, sulfur and three oxygen atoms and the fact that carboxylic group can be 
deprotonated alliin can bind metal ions as neutral or anionic mono-, bi- and tridentate ligand 
(Inset in Fig. 3). 
In the solid state alliin exists as a zwitterion35 exhibiting typical vibrations corresponding to 
asymmetric and symmetric stretching of deprotonated carboxylic group and bending of 
protonated amine group at 1611, 1391 and 1525 cm-1, respectively. Upon coordination to 
ruthenium through amine or carboxylic group these bands experience shifting. If the 
coordination occurs through nitrogen band corresponding to bending of ammonium group 
(1525 cm-1) disappears in spectrum of complexes14, 15 while band corresponding to C-N 
stretching (993 cm-1) is shifted toward lower wavenumber (~945 cm-1) due to weakening of 
C-N bond as a consequence of Ru-N bond formation. In spectrum of complex (3), where no 
amine coordination was observed, this band is not significantly affected and it is found at 998 
cm-1. Another coordination site of alliin is carboxylate group which coordinates metal ions in 
unidentate or bidentate fashion. Distinction between these coordination modes can be made 
by comparing the difference between asymmetric (νasym) and symmetric (νasym) stretching 
modes in ligand and complex.38 If the difference Δ(COO-) in complex is larger compared to 
pristine ligand than carboxylate is coordinated as unidentate ligand. On the other hand, 
reduction in Δ(COO-) upon coordination indicates bidentate coordination of carboxylate. In 
case of complexes (2) and (3) the difference Δ(COO-) is 249 and 243 cm-1, respectively which 
is larger compared to 220 cm-1 as observed in spectrum of alliin. This clearly indicates 
unidentate coordination of carboxylate to ruthenium in complexes (2) and (3). As for the 
complex (1) a new band at 1738 cm-1 corresponding to protonated carboxylic group was 
observed, thus confirming that no coordination of alliin through carboxylic oxygen took a 
place.15 This finding is consistent with the fact that the same band is found in the spectrum of 
alliin hydrochloride at 1740 cm-1. 
The third potential coordination site of alliin is sulfoxide group. Sulfoxides are ambidentate 
ligands that can coordinate metal ions through sulfur or oxygen atom. If the coordination is 
achieved through oxygen atom this gives rise to higher polarization of S-O bond thus 
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wakening S=O bond and causing shifting of ν(S=O) to lower wavenumbers.39 Oppositely, 
coordination through sulfur atom strengthens S=O bond shifting the ν(S=O) to higher 
wavenumbers upon coordination. Considering ruthenium – alliin complexes (1) – (3) only in 
complex (1) coordination through sulfoxide group was found. In spectrum of alliin  ν(S=O) is 
observed at 1021 cm-1 and upon coordination to Ru(II) in (1) it is shifted to 1032 cm-1 hence 
confirming coordination through sulfur atom of sulfoxide group. 
Presence of S-bonded dimethyl sulfoxide to Ru(II) in complexes (1) and (2) is confirmed by 
bands appearing in 1060 – 1100 cm-1 region, which is consistent with S-bonded DMSO in 
[RuCl2(dsmo-S)3(dmso-O)].31 Bands at 1275 cm-1 appearing in spectra of (1) and (3) arise 
from S=O stretching in triflate.40
1H and 13C NMR spectra provide useful insights in composition and coordination modes of 
alliin in ruthenium – alliin complexes (1) – (3). 1H NMR spectrum of complex (1) with atom 
numbering scheme of alliin is shown in Figure 3. In complexes (1) and (2) two alliin 
molecules are coordinated to ruthenium metal center. Due to the absence of any symmetry 
operation that interconverts hydrogen atoms of two alliin molecules all hydrogens are in 
magnetically nonequivalent environments hence resonating at close but different frequencies. 
The broad and the most downfield shifted signal in spectrum of complex (1) arises from the 
carboxylic proton (-COOH) and is found at 8.3 ppm. Absence of this signal in spectra of 
complexes (2) and (3), where coordination of alliin to ruthenium is achieved through 
carboxylic oxygen, confirms deprotonation of carboxylic group and its involvement in 
coordination.
Signals of vinyl hydrogens (H5 and H6) are not significantly affected by coordination of alliin 
to ruthenium due to their relative distance from the coordination sites. The signal of H5 in 
spectrum of alliin is found at 5.9 ppm and in spectra of complexes (1) – (3) it appears in 5.6 – 
6.0 ppm region.14, 37 The position of H6 signal in alliin and corresponding complexes (1) – (3) 
is basically unchanged appearing in all cases in 5.4 – 5.6 ppm region.
The signals of other alliin hydrogen atoms (H2, H3 and H4) experiences shifting upon 
coordination due to their proximity to metal center.14, 15 Coordination of alliin typically cause 
downfield shifting of these signals as previously observed in metal complexes with alliin and 
alliin-like ligands.14, 15, 18, 21 The largest downfield shifting is found for H4. The signal of H4 
in spectrum of alliin is observed in 3.6 – 3.8 ppm and upon coordination is shifted to 3.6 – 4.3 
ppm region in spectra of complexes (1) – (3). Multiplets of H3 are found in spectra of (1) – 
(3) in 3.2 – 3.6 ppm region while appearing in the spectrum of alliin in 3.2 – 3.4 ppm region. 
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The coordination of alliin through nitrogen atom in (1) and (2) causes significant upfield shift 
of H2 from 4.2 ppm in spectrum of alliin to below 3 ppm in spectra of complexes. On the 
other hand, in case of (3), where alliin is monodentatly bound to ruthenium through 
carboxylate oxygen, this shift is significantly smaller and the corresponding signal is found at 
3.8 ppm. 
Figure 3. 1H NMR spectrum of complex (1). Inset: Atom numbering scheme for alliin. 
Several signals corresponding to dimethyl sulfoxide hydrogen atoms are found in spectra of 
complexes (1) and (2) where DMSO is bound to ruthenium as coligand. The signals at 3.3 – 
3.5 ppm arise from S-bonded DMSO, as previously observed for other ruthenium – DMSO 
complexes.41 The presence of sharp singlet in spectra of (1) and (2) at 2.7 ppm, corresponding 
to free or O-bonded DMSO, indicates that DMSO undergoes substitution or linkage 
isomerism in solution. The presence of O-bonded isomers was not observed in solid state. The 
sum of the integer values of the DMSO signals (free and S-bonded) match the number of the 
DMSO molecules present per molecular unit of (1) and (2).
13C NMR spectra of alliin and corresponding ruthenium complexes (1) – (3) can be seen as 
three sets of resonances (Fig. 4). The first set consists of only one resonance around 170 ppm 
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corresponding to carboxylic carbon (C1), the second set (near 125 ppm) involves two signals 
of C5 and C6, while three signals participate in the third set comprising the C2, C3 and C4 
atoms and are found in upfield region (50 – 65 ppm). 
Carboxylic carbon (C1) shows chemical shift at 171.4 ppm in spectrum of alliin and upon 
coordination it is found at 168.4 ppm in spectrum of (1). However, upfield shifting is not 
associated with its involvement in coordination. This shifting is also observed in platinum(II) 
complex with alliin and it is consistent with N,S-coordinaiton.15 On the other hand, downfield 
shifted signal of C1 in spectrum of (3), appearing at 175 ppm, clearly indicates coordination 
of alliin through carboxylic oxygen.14 Vinyl carbon atoms associated with positions 5 and 6, 
do not show any shifting upon coordination which is consistent with their 1H NMR spectra. 
Figure 4. 13C NMR spectrum of complex (2).
Three signals in low frequency region appearing at 54.7, 50.2 and 49.7 ppm in spectrum of 
alliin arise from C4, C2 and C3, respectively.14 Due to their proximity to the coordination 
sites of alliin the positions of these signals are the most affected by coordination. Typically, 
coordination results in their downfield shifting with the chemical shift being dependent on the 
coordination mode of alliin.14, 15 In case of complex (1), where NS coordination is found, 
these signals appear at 57.6 (C3), 55.8 (C4) and 55.2 (C2) resembling to Pt(II)-alliin 
complex.15 In the spectrum of the ruthenium-ammine complex (3) these signals are observed 
at 63.1 (C2), 61.2 (C3) and 56.1 (C4).  
Well defined septet at 47.6 ppm in spectra of complexes (1) and (2) arise from DMSO carbon 
atoms. Additionally, cationic complexes (1) and (3) exhibit quartet near 120 ppm with 
coupling constant J ~ 317 Hz hence confirming presence of triflate (CF3SO3) as counter ion.42
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Polycrystalline ruthenium – alliin complexes (1) – (3) were investigated by electron 
spin/paramagnetic resonance (ESR/EPR) spectroscopy. The complex (1) was ESR silent i.e. 
no ESR signal was detected in the investigated temperature range, as it is expected for 
diamagnetic Ru(II) ions.43, 44 The complex (3) with paramagnetic Ru(III) ions exhibits strong 
ESR signal presented in Fig. 5. The complex (2) with Ru(II) ions shows weak ESR signal 
with intensity comparable to the background signal of ESR cavity. The comparison of (2) 
signal with (3) signal could be seen in Fig. S12. 
Figure 5. The temperature dependence of ESR spectra of (3). Inset shows experimental (red line) and simulated 
(black line) spectra of (3) at room temperature.
The spectral simulation was obtained using EasySpin software.45 Ru(III) ions (4d5 
configuration) could be satisfactory described with low-spin states S = 1/2 and reduced form 
of the spin-Hamiltonian:45
𝐻 = µ𝐵 × 𝐵 × 𝑔 × 𝑆   (1)
In Eq. (1), the constant µB is Bohr magneton, g is the g-tensor, B is the magnetic field vector 
and S is the spin operator. Hyperfine interactions between electron spin S = 1/2 and nuclear 
spin I = 5/2 for two isotopes 99Ru (natural abundance 12.76%) and 101Ru (natural abundance 
17.06%)46 were not detected i.e. the hyperfine splittings were covered by total spectral 
linewidth. The spectra were simulated assuming anisotropic g-tensor and Lorentzian 
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lineshape. The obtained principal values of g-tensor are [2.29 2.13 1.93]. Here obtained 
results for g-values are in agreement with the g-values for Ru(III) complexes that can be 
found in the literature.43, 44, 47 The simulated spectrum at room temperature is shown in the 
inset of Fig. 5.
3.3. Protein binding studies
Interaction of small molecules with proteins is of the great importance regarding their 
biological availability, distribution and transport.48-50 One of the important targets of alliin – 
metal complexes might be proteins since it is known that alliin is absorbed directly to blood 
and the most abundant bimolecular targets in blood are proteins, especially albumin and 
(apo)transferrin. Taking into account that the mechanism of allicin action is related to its 
reactivity toward S-containing proteins27 and the fact that many ruthenium complexes bind 
proteins, the first reasonable step in evaluating the biological potential of ruthenium – alliin 
complexes is their interaction with proteins. 
The interaction of ruthenium – alliin complexes (1) – (3) and alliin with proteins was 
investigated by spectrofluorimetry. The intrinsic fluorescence of the most proteins arises from 
the tryptophan, tyrosine and phenylalanine hindered amino acid residues.51 In bovine serum 
albumin (BSA) two tryptophan residues, Trp-134 in first domain and Trp-212 in the second 
domain, show strong intrinsic fluorescence that dominates the emission spectrum of BSA.52 If 
the conformation of the protein is changed the microenvironment around these two residues 
changes hence altering the fluorescence intensity. This allows to investigate interaction of 
BSA with small molecules simply by measuring the changes of the fluorescence in presence 
of different complex to BSA ratios.
Typical changes of the BSA fluorescence in the presence of an increasing complex 
concentrations are shown in Fig. 6a. The linear decrease of the fluorescence with the increase 
of quencher concentrations was observed for all ruthenium complexes (1) – (3) and alliin. It 
was found that the decrease obeys to Stern – Volmer equation53 (Eq. 2):
𝐼0
𝐼 = 1 + 𝐾𝑞𝜏0[𝑐𝑜𝑚𝑝𝑙𝑒𝑥] = 1 + 𝐾𝑆𝑉[𝑐𝑜𝑚𝑝𝑙𝑒𝑥] (2)
where I0 and I are fluorescence intensities in absence and presence of complex, respectively 
and Kq is quenching rate constant, τ0 is average lifetime in the absence of the quencher (τ0 = 
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10-8 s) and [complex] is the concentration of complex and KSV is the quenching constant. 
Plotting the I0/I versus [complex] gives KSV values. 
The KSV values are 103 – 104 M-1 thus suggesting that the noticeable interaction between BSA 
and complexes occurs (Table 1). More precisely, KSV values larger than 104 M-1 indicate there 
is a significant conformational change of the protein.54 The KSV values decrease in order (3) > 
(1) > (2) > alliin, regardless to temperature. The decrease of the KSV with the increase of the 
temperature for individual complexes suggest that the quenching occurs through static 
mechanism.51 Two main mechanism by which fluorescence can be quenched are static and 
dynamic. In case of the static quenching fluorophore and the quencher form adduct in the 
ground state, while in the case of the dynamic quenching energy transfer occurs in the excited 
state.55 Since the temperature increases the number of the individual collision between BSA 
and complex the quenching constant also increases. This is typical for dynamic quenching. On 
contrary, increase in temperature destabilizes the BSA-complex adduct thus decreasing the 
quenching constant in the case of static quenching56. Another valuable evidence that 
ruthenium complexes with alliin (1) – (3) quench BSA fluorescence through static quenching 
is quenching rate constant that has values of 1011 – 1012 M-1 s-1 (Table 1). The maximal 
constant rate for the dynamic quenching is 2 × 1010 M-1 s-1.51 
Figure 6. Interaction of (3) with BSA: a) quenching the BSA fluorescence in presence of increasing 
concentrations of (3), b) graphical determination of the binding constant, c) van't Hoff plot. 
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The binding constant (Kb) and number of the binding sites (n) per albumin molecule can be 
graphically obtained (Fig. S20 – S23) using Eq 3:54
𝑙𝑜𝑔
𝐼0 ― 𝐼
𝐼 = 𝑙𝑜𝑔𝐾𝑏 + 𝑛 𝑙𝑜𝑔[𝑐𝑜𝑚𝑝𝑙𝑒𝑥] (3)
The binding constant were measured at three temperatures (291, 298 and 305 K) in order to 
determine the thermodynamic parameters of the interaction (vide infra). The binding 
constants for all three complexes are 104 M-1 magnitude and are 4 – 30 times higher compared 
to alliin. However the same trend of Kb change with temperature increase was not found for 
each complex. The Kb value for complexes (2) and (3) decreases with an increase of 
temperature. On contrary, for complex (1) and pristine alliin the Kb values are greater at 
higher temperatures. This clearly indicates that the same binding forces do not govern the 
interaction of ruthenium – alliin complexes in all cases. The number of the binding sites was 
not affected by the change of the temperature and in all cases is near 1. The number of 
binding sites close to 1 often indicates that the complexes are bound to BSA in hydrophobic 
pocket of IIA or IIIA subdomain.57 Substantial evidences on the types of the forces that drive 
the interaction of complexes with BSA can be provided from thermodynamic data.
Table 1. Interaction of complexes (1) – (3) and alliin with BSA.
# T /K
KSV /
104 M-1
[conc]50 /
10-4 M
k q /
1011 M-1 s-1
Kb /
104 M-1 n
ΔH /
kJ mol-1
ΔS /
J mol-1 K-1
ΔG /
kJ mol-1
291 1.25 0.80 12.5 1.68 1.03 -23.52
298 0.89 1.12 8.93 1.98 1.07 -24.61(1)
305 0.79 1.27 7.88 2.56 1.10
22.03 156.44
-25.71
291 0.99 1.01 9.94 1.77 1.05 -23.78
298 0.75 1.33 7.49 1.46 1.06 -23.56(2)
305 0.70 1.43 6.99 0.94 1.03
-33.03 -31.79
-23.33
291 2.73 0.37 27.3 3.53 1.03 -25.32
298 2.15 0.47 21.5 2.26 1.01 -24.90(3)
305 2.24 0.45 22.4 1.57 0.97
-42.82 -60.08
-24.48
291 0.37 2.68 3.72 0.12 0.89 -16.88
298 0.31 3.19 3.13 0.13 0.92 -18.17HL
305 0.34 2.91 3.44 0.23 0.96
36.92 184.78
-19.46
Enthalpy change (ΔH) and entropy change (ΔS) can be obtained graphically from van’t Hoff 
plot (lnK vs 1/T) using equation (4): 
𝑙𝑛𝐾 = ― ∆𝐻𝑅𝑇 + ∆𝑆𝑅  (4)
Page 19 of 53 New Journal of Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Page 19 of 28
where R is the gas constant. Over the small temperature range enthalpy change can be 
considered constant and Gibbs energy change can be calculated using equation (5):
∆𝐺 = ∆𝐻 ― 𝑇∆𝑆 (5)
Data on thermodynamic parameters are summarized in Table 1. Different types of interactions 
between BSA and complexes cause different changes of thermodynamic parameters:58, 59 (i) 
ΔG > 0, ΔS < 0, ΔH < 0 indicate partial immobilization, (ii) ΔG < 0, ΔS > 0, ΔH > 0 indicate 
hydrophobic interactions, (iii) ΔG < 0, ΔS > 0, ΔH ~ 0 indicate electrostatic interaction, (iv) 
ΔG < 0, ΔS < 0, ΔH < 0 indicate van der Walls interactions and hydrogen bonding, (v) ΔH > 
120 kJ mol-1 indicate covalent biding. 
Results indicate that the interaction of ruthenium – alliin complexes with BSA are 
spontaneous under investigated conditions i.e. Gibbs energy change is negative. No 
significant differences in ΔG value was observed among complexes. On the other side, 
significant changes were observed in ΔH and ΔS values among complexes. Positive values of 
enthalpy and entropy change were found for interaction of complex (1) and alliin with BSA. 
This clearly indicates that the same type of binding forces are responsible for interaction of 
alliin and complex (1) with BSA. Here, the nature of these forces is predominantly 
hydrophobic.58 Negative values of enthalpy and entropy change were found for the interaction 
of (2) and (3) with BSA hence indicating that van der Waals forces and hydrogen bonding 
govern the interaction.58 From structural point of view these differences in the type of binding 
forces of complexes (1) – (3) with BSA can be addressed to different coordination modes of 
alliin. For pristine alliin and complex (1) the most obvious mutual structural feature is free 
carboxylic group. At pH 7.42 BSA exist in anionic form (pI ~ 4.8).60 Also, carboxylic group 
of alliin and complex (1) is susceptible to deprotonation i.e. the pKa values of the most amino 
acids are close to 2.61 These negative charges are aggravating factor in interaction of small 
molecules with bimolecular anions such proteins or DNA. In complexes (2) and (3) 
coordination of alliin to ruthenium is achieved through deprotonated carboxylate oxygen and 
in complex (2) additionally through amine nitrogen. Stronger biding to BSA was found for 
complex (3) which can be attributed not only to van der Waals forces and hydrogen bonding 
but also to electrostatic interactions since (3) is cationic complex compared to neutral (2). The 
obvious differences in interaction of (1) and (2) with BSA clearly indicate that the 
coordination mode of alliin can alert interaction of complex specie with BSA. Different 
binding forces that drive the interaction of complexes with BSA are obvious in perturbation of 
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the order in which the Kb value decreases with temperature. At 291 K the Kb decreases in 
order (3) > (2) > (1), while at 305 K the order changes and Kb decreases as (1) > (3) > (2). 
This means that the resulting adduct of complex – BSA interaction is weakened in case of (2) 
and (3) as the temperature increases. Oppositely, stronger interaction with BSA is observed 
with temperature increase in case of (1) and alliin. This suggest that the number of collisions 
between BSA and complex (1) or alliin in excited state is highly competitive and can prevail 
lower efficiency in energy transfer due to the decreased stability of BSA – complex adduct in 
ground state. 
The distance between fluorophore and complex at which the energy transfer occurs can be 
determined by Forster’s theory. The efficiency of the energy transfer is dimensionless and can 
be calculated from fluorescence intensities of BSA in presence (I) and absence (I0) of 
complex using equation (6):62
𝐸 = 1 ― 𝐼𝐼0 = 𝑅60𝑅60 + 𝑟6 (6)
The parameter r is the distance between the donor and acceptor and R0 is the critical distance 
when the transfer efficiency is 50%. The critical distance can be calculated from 
experimentally determined overlapping integral value (J) by equation (7):62
𝑅60 = 8.8 × 10 ―25𝐾2𝛷𝐽𝑁 ―4   (7)
where K2 = 2/3, N = 1.336 and φ = 0.118 are constants for BSA. The overlapping integral 
value was calculated from luminescence intensity of the fluorescent donor (F(λ)) at the 
wavelength λ and the extinction coefficient (ε(λ)) using equation (8):63
𝐽 = ∑𝐹(𝜆)𝜀(𝜆)𝜆4∆𝜆∑𝐹(𝜆)∆𝜆    (8)
Page 21 of 53 New Journal of Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Page 21 of 28
Figure 7. Overlap of the absorption spectrum of (3) and emission spectrum of BSA.
The overlapping between absorption spectrum of (3) and emission spectrum of BSA is given 
in Figure 7. The distance values (r) lower than 8 nm (2.46 – 2.64 nm) confirm that the non-
radiative energy transfer took a place.51 The critical distance increases in order aliin < (1) ~ 
(2) < (3) (Table 2). 
Table 2. Data on energy transfer and synchronous spectra of BSA and ruthenium complexes (1) – (3) and alliin.
Intensity decrease# J / cm3 L mol-1 E Ro / nm r / nm Δλ = 15 nm Δλ = 60 nm
(1) 1.00 × 10-15 0.096 1.67 2.43 8% 10%
(2) 1.06 × 10-15 0.097 1.69 2.45 5% 10%
(3) 4.74 × 10-15 0.232 2.16 2.64 18% 24%
HL 5.64 × 10-16 0.050 1.52 2.48 10% 6%
Synchronous spectra can give information on the microenvironment changes of tyrosine and 
tryptophan, two amino acids that show intrinsic fluorescence in BSA.64 Consideration criteria 
include intensity and position changes of the emission maximum when difference between 
emission and excitation wavelength is fixed (Δλ = λem – λex). The synchronous fluorescence 
maximum of tyrosine is observed when Δλ = 15 nm and tryptophan when Δλ = 60 nm (Fig. 
8).65 No obvious or regular change in the position of the emission maximum of tyrosine or 
tryptophan was observed in neither the one case when synchronous measurements were done. 
Yet conformational change of the BSA is evident since the intensity of the synchronous 
fluorescence of both amino acids is affected (Table 2). Complexes showed stronger quenching 
of tryptophan fluorescence while alliin rather quench tyrosine fluorescence. This could 
suggest that alliin and complexes (1) – (3) have different biding sites on BSA. 
Page 22 of 53New Journal of Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Page 22 of 28
Figure 8. Decrease of the fluorescence in synchronous spectra of BSA in presence of increasing concentration of 
(3) at: a) Δλ = 15 nm and b) Δλ = 60 nm.
Deeper insight in the conformational change of BSA and changes of the microenvironment 
around tryptophan and tyrosine in presence of complexes and alliin was provided from 3D 
fluorescence measurements. Typical three-dimensional fluorescence spectra of BSA in 
absence and presence of complexes (3) are shown Figure 9 (see also Fig. S18). Two peak are 
found in 3D spectra of BSA. Peak I corresponds to intrinsic fluorescence of tyrosine and 
tryptophan while Peak II is associated with conformational changes of the polypeptide 
backbone.51 The intensity of both peaks decreased in presence of complexes (1) – (3) and 
alliin. The larger decrease was observed for Peak II (22 – 30 %) compared to Peak I thus 
suggesting that the conformational change of the BSA polypeptide chain is the prevalent 
result of its interaction with ruthenium – alliin complexes (1) – (3). The values of the Stokes 
shift for peak I are lower for BSA – complexes adducts compared to native BSA thus 
suggesting that the hydrophobicity around tryptophan and/or tyrosine has changed (Table 3). 
Slight increase of Stokes shift was observed for peak II in presence of complexes (1) and (3). 
Three-dimensional fluorescence spectroscopy confirmed the results acquired by classical 
fluorescence measurement (vide supra): complexes having alliin bound through carboxylate 
oxygen to ruthenium show more similarity in interaction with BSA and bind it more tightly 
compared to species having ionized carboxylate group (alliin and (1)).
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Figure 9. Three-dimensional fluorescence spectrum of BSA (a) and BSA in presence of complex (3) (b) at 
[BSA] = 1.71 µM and [complex] = 12.5 µM. 
Table 3. Three-dimensional fluorescence spectra data on interaction of complexes (1) – (3) and alliin with BSA.
Peak I Peak II
#
λex / nm λem / nm Δλ / nm Intensity decrease λex / nm λem / nm Δλ / nm Intensity decrease
BSA 280 350 70 - 230 347 117 -
(1) 280 348 68 16% 230 349 119 22%
(2) 280 349 69 24% 230 347 117 30%
(3) 280 348 68 28% 230 348 118 30%
HL 280 349 69 15% 230 346 116 15%
The interaction of ruthenium – alliin complexes (1) – (3) and alliin with apo-transferrin was 
investigated by spectrofluorimetry. Apo-transferrin and transferrin are considered as potential 
natural ruthenium-based drug carriers since there is a hypothesis that ruthenium compounds 
could be more selectively delivered to target malignant cells by using transferrin receptor 
overexpression route.66 
Measurements showed that quenching constants are 103 M-1 order except for complex (3) 
where constant has 104 M-1 magnitude (Table 4). Similarly to interaction with BSA, 
quenching constant rates indicate static mechanism and formation of adduct in ground state. 
Generally, measurements showed that complexes have lower affinity for apo-transferrin 
compared to BSA and more detail studies were not undertaken. Lower affinity of ruthenium 
complexes to apo-transferrin compared to BSA is often encountered.29  
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Table 4. Interaction of complexes (1) – (3) and alliin with apo-transferrin. 
# KSV / 103 M-1 [conc]50 / 10-4 M kq / 1011 M-1 s-1 Kb / 103 M-1 n
(1) 9.49 1.05 9.49 10.8 1.01
(2) 8.66 1.15 8.66 2.97 0.90
(3) 19.60 0.51 19.6 62.9 1.10
HL 2.97 3.36 2.97 0.23 0.77
3.3. In vitro biological activity
The antiproliferative testing was aimed to screen the effects of complexes (1) – (3) and alliin 
on human tumor cell lines, as well as on normal (diploid) human fibroblasts (control cell line) 
in order to find potential candidates for further pre-clinical evaluation. Substances showing a 
differential anti-proliferative effect at micromole concentrations are suited for further 
biological studies and optimization. 
Results of antiproliferative testing are summarized in Table S2. All compounds exerted high 
cytotoxicity on HFF-1 (fibroblast cells) and no antiproliferative effects on tumor cells (IC50 
>100 µM). Compound (3) has showed strange effect on HeLa, SW620 and HFF-1 cells. Its 
effects on cells were particularly difficult to evaluate as it acted antiproliferatively (20-40%) 
on CFPAC-1 and in SW620 (33-64%) in all tested concentrations. The growth-response 
curves for (3) were unusual and did not follow the rule of dose-response. Ruthenium – alliin 
complexes (1) – (3) did not show significant in vitro anticancer activity, however their in vivo 
activity can be substantially different as previously observed with ruthenium complexes 
having antimetastatic activity.67, 68 Similarly, palladium(II) and platinum(II) complexes with 
alliin did not show significant anticancer activity except moderate activity toward HeLa.14, 15
Antimicrobial activity of complexes and alliin was evaluated on strains of Gram-positive 
Staphylococcus aureus, Gram-negative Pseudomonas aeruginosa, Escherichia coli and fungi 
Candida albicans. Complexes (1) – (3) and alliin did not show any antimicrobial activity at 
tested concentrations. Although some papers report antibacterial activity of complexes with 
alliin-like ligands at high concentrations20 (e. g. 0.1% w/v) we did not took experiments to test 
it at such high doses since they do not have practical applicability. Further testing will focus 
on the antimicrobial activity of complexes in presence of alliinase, an enzyme that catalyzes 
the conversion of alliin to allicin, unsaturated thiosulfinate compound that showed high 
potency as antimicrobial agent. 
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4. Conclusion
Solution synthesis afforded three novel heteroleptic water-soluble ruthenium complexes 
featuring alliin structural moiety bound to metal center in different manners. All three 
complexes are low-spin having octahedrally coordinated ruthenium with: (1) two S-bonded 
DMSO molecules and two bidentate neutral N,S-donor alliin ligands, (2) one water, one S-
bonded DMSO and two bidentate monobasic O,N-donor alliin ligands and (3) five ammine 
ligands and one monodentate monobasic O-donor alliin ligand. Complexes (1) and (2) have 
diamagnetic ESR silent 4d6 Ru(II) center while complex (3) is ESR active showing 
paramagnetism corresponding to one unpaired electron of 4d5 Ru(III) metal center. 
Complexes showed considerable affinity to bind apo-transferrin and BSA with slightly higher 
preferences for albumin. Complexes quench fluorescence of both proteins by static 
mechanism hence forming complex – protein adduct in ground state. It appears that the nature 
of the binding forces between complexes and BSA is related to the coordination mode of 
alliin. Complexes having O-bound alliin predominantly interact with BSA through hydrogen 
bonding and van der Waals interactions, while the hydrophobic forces govern the interaction 
of species having ionized carboxylate group. Synchronous and three-dimensional 
fluorescence spectra revealed that complexes alter polypeptide chain conformation in BSA 
without substantial change in the polarity around tryptophan or tyrosine. Complexes did not 
show any notable in vitro anticancer or antimicrobial activity at tested concentrations and will 
be subjected to further testing under different experimental conditions. Nevertheless, results 
provide evidences that by controlling the coordination mode of the ligand, the desired 
reactivity of the complex toward specific target, such as proteins, can be addressed. 
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Figure S1. Theoretical isotopic distribution for molecular ion of complex (1). 
Figure S2. Measured isotopic distribution for molecular ion of complex (1).
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Figure S3. Theoretical isotopic distribution for molecular ion of complex (2).
Figure S4. Measured isotopic distribution for molecular ion of complex (2).
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Figure S5. Theoretical isotopic distribution for molecular ion of complex (3).
Figure S6. Measured isotopic distribution for molecular ion of complex (3).
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Figure S7. 1H NMR spectrum of complex (2).
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Figure S8. 1H NMR spectrum of complex (3).
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Figure S9. 13C NMR spectrum of complex (2).
Figure S10. 13C NMR spectrum of complex (3).
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Figure S11. Infrared spectra of alliin at different protonation of amine nitrogen and carboxylate 
oxygen, ruthenium – alliin complexes (1) – (3) and starting ruthenium compounds. 
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Table S1. Positions of the bands in infrared spectra of complexes (1) – (3), starting Ru compounds and alliin.
νs(S=O)
En
tr
y
Compound
ν s
(C
O
O
H
)
ν s
 (C
=C
)
ν s
(C
O
O
- )
δ d
(N
H
3)
δ(
N
H
2)
δ(
N
H
3+
)
ν s
(C
O
O
- )
δ(
C
H
3)
δ d
(N
H
3)
ν s
(S
=O
) 
tr
ifl
at
e
S-bonded fr
ee O
- ν s
(C
-N
)
ρ r
(N
H
3)
1. Alliin 1641
161
1
158
5
152
5
139
1
102
1
99
3
2. Alliin hydrochloride
174
0
164
0
151
4
100
8
3. Potassium alliinate
162
0
162
0
158
7
148
8
140
8
101
5
4. (1) 1738
164
0
156
5 -
140
4
138
6
127
7
108
9
103
2
94
8
5. (2) 1632
163
2
158
5 -
138
3
140
5
138
3
107
2
102
1
94
3
6. (3) 1629
162
9 -
138
7
128
7
127
9
103
2
99
8
84
3
7. [Ru(NH3)5Cl]Cl2
163
0
130
0
80
4
8. Dimethyl sulfoxide 1436
140
7
102
3
9. cis-[RuCl2(DMSO)4]
142
6
140
1
108
7
92
6
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Figure S12. The comparison of ESR signals of (2) and (3).
Page 40 of 53New Journal of Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
12 / 24
300 400320 340 360 380
500
0
50
100
150
200
250
300
350
400
450
nm
a)
300 400320 340 360 380
500
0
50
100
150
200
250
300
350
400
450
nm
b)
300 400320 340 360 380
500
0
50
100
150
200
250
300
350
400
450
nm
c)
300 400320 340 360 380
500
0
50
100
150
200
250
300
350
400
450
nm
d)
Figure S13. Quenching of the apotransferrin fluorescence in the absence and presence of an 
increasing concentrations of (1) – (3) (a – c) and alliin (d) at 298 K. 
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Figure S14. Quenching of BSA fluorescence in the absence and presence of an increasing 
concentrations of (1) – (3) (a – c) and alliin (d) at 291 K.
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Figure S15. Quenching of BSA fluorescence in the absence and presence of an increasing 
concentrations of (1) – (3) (a – c) and alliin (d) at 298 K.
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Figure S16. Quenching of BSA fluorescence in the absence and presence of an increasing 
concentrations of (1) – (3) (a – c) and alliin (d) at 298 K.
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Figure S17. Synchronous fluorescence spectra of BSA in the absence and presence of increasing 
concentrations of complexes (1) (a, b), (2) (c, d), (3) (e, f) and alliin (g, h); Δλ = 15 nm (left column) 
and Δλ = 60 nm (right column).
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Figure S18. 3D fluorescence spectra of BSA in absence (a) and presence of complex (1) – (3) (b – d) 
and alliin (e). [BSA] = 1.71 µM and [complex] = 12.5 µM.
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Figure S19. Overlap of fluorescence emission spectrum of BSA and absorption spectrum of: a) (1), b) 
(2), c) (3) and d) alliin.
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Figure S20. Graphical determination of the binding constant (Kb) and number of binding sites (n) of 
complex (1) to BSA at three temperatures: a) 291 K, b) 298 K, c) 305 K and d) van't Hoff plot. 
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Figure S21. Graphical determination of the binding constant (Kb) and number of binding sites (n) of 
complex (2) to BSA at three temperatures: a) 291 K, b) 298 K, c) 305 K and d) van't Hoff plot.
Page 49 of 53 New Journal of Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
21 / 24
Figure S22. Graphical determination of the binding constant (Kb) and number of binding sites (n) of 
complex (3) to BSA at three temperatures: a) 291 K, b) 298 K, c) 305 K and d) van't Hoff plot.
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Figure S23. Graphical determination of the binding constant (Kb) and number of binding sites (n) of 
alliin to BSA at three temperatures: a) 291 K, b) 298 K, c) 305 K and d) van't Hoff plot.
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Figure S24. Graphical determination of the binding constant (Kb) and number of binding sites (n) of 
complexes (1) – (3) (a – c) and alliin (d) with apotransferrin.
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Proliferation assays
The panel cell lines were inoculated onto a series of standard 96-well microtiter plates on day 0, at 
5000 cells per well according to the doubling times of specific cell line. Test agents were then added 
in five, 10-fold dilutions (0,01 to 100 µM) and incubated for further 72 hours. Working dilutions were 
freshly prepared on the day of testing in the growth medium. After 72 hours of incubation, the cell 
growth rate was evaluated by performing the MTT assay: experimentally determined absorbance 
values were transformed into a cell percentage growth (PG) using the formulas proposed by NIH. This 
method directly relies on control cells behaving normally at the day of assay because it compares the 
growth of treated cells with the growth of untreated cells in control wells on the same plate – the 
results are therefore a percentile difference from the calculated expected value. 
The IC50 values for each compound were calculated from dose-response curves using linear 
regression analysis by fitting the mean test concentrations that give PG values above and below the 
reference value. If, however, all of the tested concentrations produce PGs exceeding the respective 
reference level of effect (e.g. PG value of 50) for a given cell line, the highest tested concentration is 
assigned as the default value (in the screening data report that default value is preceded by a ">" 
sign). Each test point was performed in quadruplicate in two individual experiments. The results were 
statistically analyzed (ANOVA, Tukey post-hoc test at p < 0.05). Finally, the effects of the tested 
substances were evaluated by plotting the mean percentage growth for each cell type in comparison 
to control on dose response graphs.
Table S2.  IC50 values for complexes (1) – (3) and alliin. 
MCF-7 CFPAC-1 HeLa SW620 HFF-1Compound IC50 / μM
(1) >100 >100 >100 >100 0.74
(2) >100 >100 >100 >100 0.08
(3) >100 >100 33.82* >100* 89*
HL >100 >100 >100 >100 19.58
*Unusual growth response curve.
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